Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1964 Aug 8;91(6):289–292.

Preliminary Report on an Iron-Sorbitol-Citric Acid Complex (Jectofer), a New Intramuscular Iron Preparation

Dorothy C H Ley, S C Robinson
PMCID: PMC1927239  PMID: 14180535

Abstract

One hundred and twenty-eight patients with iron deficiency anemia were treated with a new intramuscular iron preparation, iron-sorbitol-citric acid. One group of 10 patients received a total of 1000 mg. each of elemental iron intramuscularly. All obtained a rise in hemoglobin of over 2.1 g. %, an elevation of serum iron, and a reticulocyte response over 6%. A second larger group of subjects consisted of 113 prenatal and five gynecologic patients; these received an average total dose of 1050 mg. and 1020 mg., respectively, and the average increase in hemoglobin ranged from 1.6 g. % to 2.5 g. %.

None of the patients developed significant side effects after injection or permanent staining at the site of injection. Three patients experienced a transient ache at the injection site, and three developed local urticaria-like reactions lasting 24 hours.

This new preparation appears to be a safe and clinically effective therapeutic agent in situations in which parenteral iron is indicated.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAIRD I. M., PODMORE D. A. Intramuscular iron therapy in iron-deficiency anaemia. Lancet. 1954 Nov 6;267(6845):942–946. doi: 10.1016/s0140-6736(54)92555-6. [DOI] [PubMed] [Google Scholar]
  2. COLEMAN D. H., STEVENS A. R., Jr, FINCH C. A. The treatment of iron deficiency anemia. Blood. 1955 Jun;10(6):567–581. [PubMed] [Google Scholar]
  3. FIELDING J. Intravenous iron-dextrin in iron-deficiency anaemia. Br Med J. 1961 Jul 29;2(5247):279–283. doi: 10.1136/bmj.2.5247.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HADDOW A., HORNING E. S. On the carcinogenicity of an iron-dextran complex. J Natl Cancer Inst. 1960 Jan;24:109–147. [PubMed] [Google Scholar]
  5. LUNDIN P. M. The carcinogenic action of complex iron preparations. Br J Cancer. 1961 Dec;15:838–847. doi: 10.1038/bjc.1961.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. RICHMOND H. G. Induction of sarcoma in the rat by iron-dextran complex. Br Med J. 1959 Apr 11;1(5127):947–949. doi: 10.1136/bmj.1.5127.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SVARD P. O., LINDVALL S. Mechanism of absorption of two intramuscular iron preparation. J Pharm Pharmacol. 1961 Nov;13:650–653. doi: 10.1111/j.2042-7158.1961.tb11887.x. [DOI] [PubMed] [Google Scholar]
  8. WETHERLEY-MEIN G., BUCHANAN J. G., GLASS U. H., PEARCE L. C. Metabolism of 59Fe-sorbitol complex in man. Br Med J. 1962 Jun 30;1(5295):1796–1800. doi: 10.1136/bmj.1.5295.1796. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES